Ph.D., UNSW Sydney Australia, 1990

Professor Lysaght's area of specialization is the therapeutic application of synthetic membranes and other barrier materials in hemodialysis, apheresis, and tissue engineering. He also studies the complex interplay of technology, economics, and public policy in shaping contemporary and emerging organ-replacement therapies and has recently described this in several influential publications.

While at Brown, Dr. Lysaght's laboratory research has focused on new therapies for End Stage Renal Disease, and tissue engineering approaches to the treatment of diabetes and of deteriorating cartilage. His current research projects focus on delivery of orthopedically relevant growth factors from microencapsulated, genetically engineered cells.

Dr. Lysaght retired from teaching in 2008. During most prior academic years, Dr. Lysaght taught three courses with an aggregate annual enrollment of 150-200 students: Organ Replacement (BI1080), Introduction to Biotechnology (BI0170), and Biotechnology Management (BI0080).

He received the Hazeltine Citation in 2003 and the Le Duc award for teaching excellence in Life Science in 2002.